Cannabidiol
Who holds supplier records for Cannabidiol? 21 organisations hold a current record for Cannabidiol: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), China (2), Italy (2), United States (2) and 6 other countries (7); not recorded for 5.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Cannabidiol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cannabidiol
Reading the evidence
- 21 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Cannabidiol expires 24 Sept 2042. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (21)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Cannabidiol. Country is the organisation's recorded country, not necessarily the manufacturing site.
- BENUVIA OPERATIONS LLCActive DMF 32552, 44478, 28255 · latest filing Sept 2026
- YUNNAN HANSU BIOTECHNOLOGY CO LTDChinaActive DMF 42679, 33498 · latest filing Sept 2025
- INDENA SPAItalyCEP Company GMP cert on recordActive DMF 35648 · latest filing Feb 2021
- AGNO PHARMAActive DMF 34861 · latest filing Aug 2020
- Alkem Laboratories LimitedIndia Company GMP cert on recordActive DMF 36744 · latest filing Feb 2022
- AVERIX BIOUnited StatesActive DMF 36798 · latest filing Feb 2022
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 35992 · latest filing Jun 2021
- DIVISION OF THERAPEUTICS AND MEDICAL CONSEQUENCESActive DMF 30658 · latest filing Sept 2016
- EVERGREEN STATE HOLDINGS LLCActive DMF 37727 · latest filing Dec 2022
- Farmabios S.p.A.Italy Company GMP cert on recordActive DMF 34029 · latest filing Jul 2019
- Hybio Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 39222 · latest filing Nov 2023
- LUPIN MANUFACTURING SOLUTIONS LTDActive DMF 39675 · latest filing Apr 2024
- Medipharm Labs IncCanada Company GMP cert on recordActive DMF 36490 · latest filing Feb 2022
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 41468 · latest filing Mar 2025
- PURISYS LLCUnited StatesActive DMF 33223 · latest filing Feb 2019
- ROLABO OUTSOURCING SLSpain Company GMP cert on recordActive DMF 40825 · latest filing Dec 2024
- SCI PHARMTECH INCTaiwanActive DMF 34635 · latest filing Sept 2020
- THC PHARM GMBHGermanyActive DMF 32715 · latest filing Apr 2018
- VERANOVA LPUnited KingdomActive DMF 32901 · latest filing Aug 2018
- BSPG Laboratories LTD.United KingdomCEP
- LINNEA S.A.SwitzerlandCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Cannabidiol, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| LINNEA S.A. Locarno | CH | CEP 2024-462 - Rev 01 Cannabidiol | May 2026 | Inspected Jul 2025 Switzerland |
| BSPG LABORATORIES LIMITED Sandwich | GB | CEP 2024-370 - Rev 00 Cannabidiol | Mar 2026 | — |
| INDENA S.P.A. Milano | IT | CEP 2024-055 - Rev 00 Cannabidiol | Dec 2024 | Inspected Jun 2026 Italy |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Cannabidiol are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- CURIA NEW YORK INCInactive DMF 30638 · filed Jun 2016
- GW PHARMA LTDInactive DMF 27824, 27030 · filed Dec 2013
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (1 listed product contain Cannabidiol). The latest listed patent expires 24 Sept 2042. The latest listed exclusivity runs to 31 Jul 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Cannabidiol is a phytocannabinoid derived from the cannabis plant that does not induce psychoactive effects. It is primarily used to treat certain forms of epilepsy and is being investigated for its potential to alleviate various conditions involving pain and inflammation.
Chemical identity
- IUPAC name
- 2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
- Canonical SMILES
- CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O
- InChIKey
- QHMBSVQNZZTUGM-FLBVKQSMSA-N
- Synonyms
- Epidiolex API
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Mechanism of action
- Cytochrome P450 1A2 Inhibitors; Cytochrome P450 2B6 Inducers; Cytochrome P450 2B6 Inhibitors; Cytochrome P450 2C19 Inhibitors; Cytochrome P450 2C8 Inhibitors; Cytochrome P450 2C9 Inhibitors; UGT1A9 Inhibitors; UGT2B7 Inhibitors
- Chemical structure
- Cannabinoids
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Cannabidiol?
21 organisations hold an active US FDA Type II Drug Master File or a CEP for Cannabidiol: BENUVIA OPERATIONS LLC, YUNNAN HANSU BIOTECHNOLOGY CO LTD (China), INDENA SPA (Italy), AGNO PHARMA, Alkem Laboratories Limited (India), AVERIX BIO (United States), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India) and DIVISION OF THERAPEUTICS AND MEDICAL CONSEQUENCES, and 13 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Cannabidiol Drug Master Files are active?
BENUVIA OPERATIONS LLC (DMF 32552, 44478), YUNNAN HANSU BIOTECHNOLOGY CO LTD (DMF 42679, 33498), INDENA SPA (DMF 35648), AGNO PHARMA (DMF 34861), Alkem Laboratories Limited (DMF 36744), AVERIX BIO (DMF 36798), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 35992) and DIVISION OF THERAPEUTICS AND MEDICAL CONSEQUENCES (DMF 30658) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Cannabidiol records mean?
2 organisations have only inactive Type II DMFs for Cannabidiol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Cannabidiol have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Cannabidiol on the EDQM register, including LINNEA S.A. Locarno (CH), BSPG LABORATORIES LIMITED Sandwich (GB) and INDENA S.P.A. Milano (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Cannabidiol?
Yes. The latest patent listed for an approved US product containing Cannabidiol expires 24 Sept 2042, across 1 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Cannabidiol supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Cannabidiol?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.